Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

Certain genes are linked to the risk of developing Alopecia Areata.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

The woman's facial symptoms are best explained by primary Sjögren’s Syndrome.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Many children with alopecia areata also have other autoimmune diseases.

Autoimmune skin disorders are caused by genetic and environmental factors and are treated with various medications and preventative strategies.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

People with alopecia areata have higher levels of a heart disease marker in their blood.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Alopecia areata and polymyalgia rheumatica may be linked autoimmune conditions.

Monoclonal antibodies are often linked to alopecia areata cases.

Blocking LFA-1 prevents hair loss in mice.

Belimumab may cause hair loss in lupus patients.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Women with PCOS have higher levels of thyroid autoantibodies.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

People with chronic hives should be tested for thyroid autoimmunity to manage their condition better.